{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:55:09Z","timestamp":1794254109213,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2024JH2\/102600306"],"award-info":[{"award-number":["2024JH2\/102600306"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2412066"],"award-info":[{"award-number":["XLYC2412066"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272749"],"award-info":[{"award-number":["82272749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.radonc.2026.111527","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:29:33Z","timestamp":1775755773000},"page":"111527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of rhuGM-CSF on prevention and treatment of oral mucositis in patients receiving radiotherapy for head and neck cancer: A randomized controlled trial"],"prefix":"10.1016","volume":"219","author":[{"given":"Wenxuan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-3771","authenticated-orcid":false,"given":"Qiao","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111527_b0005","first-page":"141","article-title":"Decitabine combined with CAG regimen in the treatment of elderly patients with acute myeloid leukemia","volume":"36","author":"Zhao","year":"2020","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.radonc.2026.111527_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020440","article-title":"Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: a way to Overcome Immunotherapy Resistance?","volume":"14","author":"Martori","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111527_b0015","doi-asserted-by":"crossref","first-page":"28226","DOI":"10.18632\/oncotarget.24890","article-title":"Evaluation of effectiveness of granulocyte-macrophage colony-stimulating factor therapy to cancer patients after chemotherapy: a meta-analysis","volume":"9","author":"Yu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2026.111527_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37265","article-title":"Severe Oral Mucositis after Intensity-Modulated Radiation Therapy for Head and Neck Cancer","volume":"6","author":"Iovoli","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2026.111527_b0025","article-title":"Oral Mucositis Induced by Chemoradiotherapy in Head and Neck Cancer-a Short Review about the Therapeutic Management and the Benefits of Bee Honey","volume":"58","author":"Jicman Stan","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.radonc.2026.111527_b0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111527_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104751","article-title":"Comparative prevention potential of 10 mouthwashes on intolerable oral mucositis in cancer patients: a Bayesian network analysis","volume":"107","author":"Zhang","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278102","article-title":"Effects of various treatments for preventing oral mucositis in cancer patients: a network meta-analysis","volume":"17","author":"Peng","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111527_b0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1345\/aph.10311","article-title":"Granulocyte macrophage-colony stimulating factor and oral mucositis","volume":"36","author":"Fung","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.radonc.2026.111527_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02990946","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients","volume":"14","author":"Ibrahim","year":"1997","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0973-1482.19589","article-title":"The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma","volume":"1","author":"Patni","year":"2005","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2026.111527_b0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/MO:22:3:247","article-title":"Therapeutic efficacy by recombinant human granulocyte\/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study","volume":"22","author":"Masucci","year":"2005","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102093","article-title":"A randomized clinical trial of granulocyte macrophage colony stimulating factor mouthwash for oral mucositis in head and neck cancer","volume":"56","author":"Dodd","year":"2022","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.radonc.2026.111527_b0070","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s11136-014-0628-5","article-title":"The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial","volume":"23","author":"Hoffman","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.radonc.2026.111527_b0075","first-page":"197","article-title":"Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs","volume":"10","author":"Mantovani","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2026.111527_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"TROG consensus guidelines Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0090","article-title":"Magnetic Resonance Imaging-based Delineation of Organs at risk in the Head and Neck Region","volume":"8","author":"Paczona","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111527_b0105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ijrobp.2008.02.072","article-title":"The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111527_b0110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hed.20602","article-title":"Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module","volume":"29","author":"Rosenthal","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2026.111527_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102661","article-title":"Predictive Risk Factors Associated with Severe Radiation-Induced Mucositis in Nasopharyngeal or Oropharyngeal Cancer patients: a Retrospective Study","volume":"10","author":"Kawashita","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2026.111527_b0120","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41416-020-01106-x","article-title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy","volume":"124","author":"Ng","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2026.111527_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194444","article-title":"Neutrophil-to-Lymphocyte Ratio as a factor predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer patients Treated with Radiotherapy","volume":"10","author":"Homa-Mlak","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2026.111527_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123113","article-title":"The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation score in a Head and Neck Cancer Cohort","volume":"11","author":"Yeh","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2026.111527_b0135","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1002\/cam4.3150","article-title":"Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2026.111527_b0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the Common Terminology Criteria for adverse events (CTCAE - Version 5.0) to Evaluate the Severity of adverse events of Anticancer Therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.radonc.2026.111527_b0145","first-page":"1405","article-title":"Modeling symptom drivers of oral intake in long-term head and neck cancer survivors","volume":"27","author":"Kamal","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2026.111527_b0150","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.23.00837","article-title":"Streptococcus salivarius K12 Alleviates Oral Mucositis in patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: a Randomized Controlled Trial","volume":"42","author":"Peng","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111527_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091236","article-title":"Poor Vitamin Status is Associated with Skeletal Muscle loss and Mucositis in Head and Neck Cancer patients","volume":"10","author":"Nejatinamini","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.radonc.2026.111527_b0160","first-page":"6061","article-title":"Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers","volume":"29","author":"Villa","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2026.111527_b0165","first-page":"2969","article-title":"Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis","volume":"25","author":"Normando","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2026.111527_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267092","article-title":"Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: a pilot study","volume":"17","author":"Kiyomi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111527_b0175","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-18-1038","article-title":"Resistance to Radiotherapy and PD-L1 Blockade is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration","volume":"24","author":"Oweida","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111527_b0180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038355","article-title":"T lymphocyte and neutrophil\/lymphocyte ratio in patients with radiation-induced oral mucositis after intensity-modulated radiation therapy for head and neck cancer: a retrospective single-center study","volume":"103","author":"Qi","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.radonc.2026.111527_b0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","article-title":"Oral mucositis: the hidden side of cancer therapy","volume":"39","author":"Pulito","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111527_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413490","article-title":"Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas","volume":"25","author":"Brust","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111527_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316995","article-title":"Attempts to Understand Oral Mucositis in Head and Neck Cancer patients through Omics Studies: a Narrative Review","volume":"24","author":"San Valentin","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:05:17Z","timestamp":1789751117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S016781402600366X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111527","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of rhuGM-CSF on prevention and treatment of oral mucositis in patients receiving radiotherapy for head and neck cancer: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111527"}}